Single-port Extraperitoneal and Transperitoneal Radical Prostatectomy: A Multi-Institutional Propensity-Score Matched Study.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2023
Historique:
received: 19 05 2022
revised: 21 09 2022
accepted: 02 10 2022
pubmed: 17 10 2022
medline: 11 1 2023
entrez: 16 10 2022
Statut: ppublish

Résumé

To compare the perioperative and early postoperative outcomes between single-port (SP) extraperitoneal radical prostatectomy (EPRP) and SP transperitoneal radical prostatectomy (TPRP), in a multi-institutional setting. We identified all patients who underwent SP robot-assisted radical prostatectomy at 6 different institutes. Data of 650 patients were collected and divided into 2 groups based on the surgical approach: SP EPRP or SP TPRP. A Propensity-score matched-pair analysis for body mass index (BMI), prostate size, and National Comprehensive Cancer Network risk was performed with a 1:1 ratio. Analysis of perioperative and postoperative outcomes was performed using Wilcoxon signed-rank test and chi-square and Fisher's exact tests. After matching, 238 patients were included in each arm. The median follow-up period was 7 and 6 months for EPRP and TPRP groups, respectively. The total operative time was longer in the EPRP group (206 vs 155 minutes, P < .001). The EPRP group had a shorter length of hospitalization and same-day discharge rate compared to the TPRP approach (P < .001). There was no difference in the overall intraoperative or postoperative complications rate between the 2 groups, nor positive surgical margin rates. The SP extraperitoneal approach is associated with a shorter hospital stay and higher rate of same-day discharge, with no difference in the surgical margin, or complication rates.

Identifiants

pubmed: 36244472
pii: S0090-4295(22)00874-3
doi: 10.1016/j.urology.2022.10.001
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-145

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Mahmoud Abou Zeinab (M)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH.

Alp Tuna Beksac (AT)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH.

Ethan Ferguson (E)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH.

Aaron Kaviani (A)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH.

Marcio Covas Moschovas (MC)

Global Robotics Institude, Celebration, FL.

Jean Joseph (J)

University of Rochester, Rochester, NY.

Moses Kim (M)

Hoag Hospital, Newport Beach, CA.

Simone Crivellaro (S)

University of Illinois Hospital & Health Sciences System, Chicago, IL.

Jeffrey Nix (J)

University of Alabama Birmingham, Birmingham, AL.

Vipul Patel (V)

Global Robotics Institude, Celebration, FL.

Jihad Kaouk (J)

Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: kaoukj@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH